Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Staphylococcus epidermidis (56500) |
- |
- |
0.063 - ? |
DU-6856  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
0.063 - ? |
Sitafloxacin  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
0.25 - ? |
DU-6857  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
0.25 - ? |
DU-6858  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
0.5 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
0.5 - ? |
Levofloxacin (Levaquin, Quixin)  |
332 |
Staphylococcus epidermidis (56500) |
- |
- |
1 - ? |
Ofloxacin (Floxin)  |
332 |
Staphylococcus epidermidis (81388 CANWARD 2008 + meticillin-susceptible) |
- |
2 |
? - ? |
Benzalkonium chloride  |
1524 |
Staphylococcus epidermidis (887E + methicillin-resistant) |
- |
- |
1 - ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
224 |
Staphylococcus epidermidis (887E + methicillin-resistant) |
- |
- |
2 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
224 |
Staphylococcus epidermidis (887E) |
- |
- |
0.13 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
78 |
Staphylococcus epidermidis (A233) |
- |
- |
7.81 - ? |
Thymus spathulifolius (Methanol extract - Chloroform subfraction)  |
411 |
Staphylococcus epidermidis (A233) |
- |
- |
15.62 - ? |
Cefepime hydrochloride (Maxipime)  |
1345 |
Staphylococcus epidermidis (A233) |
- |
- |
15.62 - ? |
Cefepime hydrochloride (Maxipime)  |
1102 |
Staphylococcus epidermidis (A233) |
- |
- |
15.62 - ? |
Sulbactam  |
176 |
Staphylococcus epidermidis (A233) |
- |
- |
62.5 - ? |
Cefepime hydrochloride (Maxipime)  |
1344 |
Staphylococcus epidermidis (A233) |
- |
- |
62.5 - ? |
Summer savory (Methanol extract)  |
1344 |
Staphylococcus epidermidis (A233) |
- |
- |
125 - ? |
Origanum acutidens (Essential oil)  |
176 |
Staphylococcus epidermidis (A233) |
- |
- |
125 - ? |
Satureja hortensis (Summer savory) (Essential oil)  |
1344 |
Staphylococcus epidermidis (A233) |
- |
- |
125 - ? |
Thymus spathulifolius (Essential oil)  |
411 |
Staphylococcus epidermidis (A233) |
- |
- |
? - 15.62 |
Cefoperazone/Sulbactam  |
411 |
Staphylococcus epidermidis (ATCC 12228 + methicillin-resistant) |
- |
- |
1 - ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
193 |
Staphylococcus epidermidis (ATCC 12228 + methicillin-resistant) |
- |
- |
1 - ? |
PH-027  |
193 |
Staphylococcus epidermidis (ATCC 12228 + methicillin-resistant) |
- |
- |
2 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
193 |
Staphylococcus epidermidis (ATCC 12228) |
3.12 |
6.25 |
? - ? |
Silver nanoparticles  |
776 |
Staphylococcus epidermidis (ATCC 12228) |
- |
- |
0.025 - 0.05 |
Bambermycins (Moenomycin)  |
366 |
Staphylococcus epidermidis (ATCC 12228) |
- |
- |
0.125 - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin)  |
397 |
Staphylococcus epidermidis (ATCC 12228) |
- |
- |
0.125 - ? |
Minocycline (Minocycline hydrochloride, Minocin)  |
397 |